Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology

Abstract

Background

Depression and anxiety are established psychosocial risk factors for coronary heart disease. Contemporary data on their prevalence and associations with other risk factors were evaluated as part of the EUROASPIRE IV survey.

Design

The design of this study was cross-sectional.

Methods

The study group consisted of 7589 patients from 24 European countries examined at a median of 1.4 years after hospitalisation due to coronary heart disease events. Depression and anxiety were assessed using the Hospital Anxiety and Depression Scale.

Results

Symptoms of anxiety (Hospital Anxiety and Depression Scale-Anxiety score ≥8) were seen in 26.3% of participants and were more prevalent in women (39.4%) vs men (22.1%). Of the patients, 22.4% (30.6% of women and 19.8% of men) had symptoms of depression (Hospital Anxiety and Depression Scale-Depression score ≥8). Nevertheless, antidepressants and anti-anxiety medications were prescribed to only 2.4% of patients at hospital discharge, and 2.7% and 5.0% of patients, respectively, continued to take them at interview. Both anxiety and depression were associated with female gender, lower educational level and more sedentary lifestyle. Anxiety was more prevalent in younger age groups and depression rates increased with advancing age. Depression was positively associated with current smoking, central obesity and self-reported diabetes. A number of positive lifestyle changes reduced the odds of anxiety and depression.

Conclusions

A substantial proportion of patients have anxiety and depression symptoms after coronary heart disease events but these conditions are undertreated. These disorders, especially depression, are associated with other risk factors, including educational level, sedentary lifestyle, smoking, unhealthy diet and reduced compliance with risk factor modification.

Keywords

Anxiety cardiovascular risk coronary artery disease depression

Get full access to this article

View all access options for this article.

References

Perk

De Backer

Gohlke

et al.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012; 33: 1635–1701.

Pogosova

Saner

Pedersen

et al.

Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol 2015; 22: 1290–1306.

Rosengren

Hawken

Ounpuu

et al.

Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 953–962.

Gan

Gong

Tong

et al.

Depression and the risk of coronary heart disease: A meta-analysis of prospective cohort studies. BMC Psychiatry 2014; 14: 371–371.

Rugulies

. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002; 23: 51–61.

Wulsin

Singal

. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003; 65: 201–210.

Nicholson

Kuper

Hemingway

. Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763–2774.

Tully

Cosh

Baumeister

. The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. J Psychosom Res 2014; 77: 439–448.

Roest

Martens

de Jonge

et al.

Anxiety and risk of incident coronary heart disease: A meta-analysis. J Am Coll Cardiol 2010; 56: 38–46.

10.

Roest

Martens

Denollet

et al.

Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosom Med 2010; 72: 563–569.

11.

Meijer

Conradi

Bos

et al.

Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33: 203–216.

12.

Nabi

Shipley

Vahtera

et al.

Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: The Whitehall II cohort study. Heart 2010; 96: 1645–1650.

13.

Watkins

Koch

Sherwood

et al.

Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. J Am Heart Assoc 2013; 2: e000068–e000068.

14.

Carney

Freedland

Steinmeyer

et al.

Depression and five year survival following acute myocardial infarction: A prospective study. J Affect Disord 2008; 109: 133–138.

15.

Ziegelstein

Fauerbach

Stevens

et al.

Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160: 1818–1823.

16.

Doyle

Rohde

Rutkowska

et al.

Systematic review and meta-analysis of the impact of depression on subsequent smoking cessation in patients with coronary heart disease: 1990–2013. Psychosom Med 2014; 76: 44–57.

17.

DiMatteo

Lepper

Croghan

. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–2107.

18.

Gehi

Haas

Pipkin

et al.

Depression and medication adherence in outpatients with coronary heart disease: Findings from the Heart and Soul Study. Arch Intern Med 2005; 165: 2508–2513.

19.

Rieckmann

Kronish

Haas

et al.

Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006; 152: 922–927.

20.

Carney

Blumenthal

Stein

et al.

Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024–2028.

21.

Taylor

Conrad

Wilhelm

et al.

Psychophysiological and cortisol responses to psychological stress in depressed and nondepressed older men and women with elevated cardiovascular disease risk. Psychosom Med 2006; 68: 538–546.

22.

Shimbo

Child

Davidson

et al.

Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol 2002; 89: 331–333.

23.

Wittstein

. Depression, anxiety, and platelet reactivity in patients with coronary heart disease. Eur Heart J 2010; 31: 1573–1582.

24.

Austin

Wissmann

von Kanel

. Stress and hemostasis: An update. Semin Thromb Hemost 2013; 39: 902–912.

25.

Severus

Littman

Stoll

. Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry 2001; 9: 280–293.

26.

Cohen

Gibson

Alderman

. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am J Med 2000; 108: 2–8.

27.

Rothenbacher

Jaensch

Mons

et al.

Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: Role of physical activity and unmet medical need. Eur J Prev Cardiol. 2015; 22: 1129–1138.

28.

Leung

Flora

Gravely

et al.

The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: Meta-analysis. Psychosom Med 2012; 74: 786–801.

29.

Rutledge

Redwine

Linke

et al.

A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med 2013; 75: 335–349.

30.

Pająk

Jankowski

Kotseva

et al.

EUROASPIRE Study Group. Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: The EUROASPIRE III Study. Eur J PrevCardiol 2013; 20: 331–340.

31.

Kotseva K, Wood D, De Bacquer D, et al.; on behalf of the EUROASPIRE Investigators. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J PrevCardiol 2016; 23: 636–648.

32.

International Physical Activity Questionnaire (IPAQ). Downloadable questionnaires. Available at: https://sites.google.com/site/theipaq/questionnaire_links (accessed 16 May 2015).

33.

Zigmond

Snaith

. The hospital anxiety and depression scale. Acta Psych Scand 1983; 67: 361–370.

34.

World Health Organization. Women’s mental health: An evidence based review. Report no.: WHO/MSD/MDP/00.1 2000: 47. Geneva: World Health Organization, 2000.

35.

Blanco

Rubio

Wall

et al.

Risk factors for anxiety disorders: Common and specific effects in a national sample. Depress Anxiety 2014; 31: 756–764.

36.

Ramamurthy G, Trejo E and Faraone SV. Depression treatment in patients with coronary artery disease: A systematic review. Prim Care Companion CNS Disord. Epub ahead of print 24 October 2013. DOI: 10.4088/PCC.13r01509.

37.

Nicholson

Kuper

Hemingway

. Depression as an etiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763–2774.

38.

Lichtman

Bigger

Jr Blumenthal

et al.

Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation 2008; 118: 1768–1775.

39.

Huffman

Celano

Beach

et al.

Depression and cardiac disease: Epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol 2013; 2013: 695925–695925.

40.

Bonnet

Irving

Terra

et al.

Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis 2005; 178: 339–344.

41.

Khosravi

Sotoudeh

Majdzadeh

et al.

Healthy and unhealthy dietary patterns are related to depression: A case-control study. Psychiatry Investig 2015; 12: 434–442.

42.

Thombs

Roseman

Coyne

et al.

Does evidence support the American Heart Association’s recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS One 2013; 8: e52654–e52654.